EMEA-001219-PIP01-11-M05
Key facts
| Invented name |
Triumeq
|
| Active substance |
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0116/2021
|
| PIP number |
EMEA-001219-PIP01-11-M05
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of human immunodeficiency virus (HIV-1) infection
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
ViiV Healthcare UK Limited
E-mail: eu.paediatric-plans@gsk.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|